TILT Holdings (TLLTF) Income from Continuing Operations (2021 - 2025)
TILT Holdings (TLLTF) reported Income from Continuing Operations of 9151000.0 for Q2 2025, up 44.71% on a YoY basis from 6323815.19 in Q2 2024, and up 30.88% quarter-over-quarter from 13240000.0 in Q1 2025.
TILT Holdings (TLLTF) Income from Continuing Operations (2021 - 2025) Analysis & Trends
TILT Holdings has reported Income from Continuing Operations for 5 years, with the latest figure at 9151000.0 in Q2 2025.
- For the quarter ending Q2 2025, Income from Continuing Operations rose 44.71% year-over-year to 9151000.0; the trailing twelve-month figure through Jun 2025 stood at 71738000.0 (down 17.95% YoY), and the FY2024 full-year result was 94945000.0, down 39.99% from the prior year.
- Income from Continuing Operations for Q2 2025 stood at 9151000.0, up from 13240000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1034000.0 in Q2 2021, with the low at 71629000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 17049470.59 across 5 years, with a median of 12649000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 1629.34% — and 2023, when it soared 63.76%.
- TILT Holdings' Income from Continuing Operations stood at 20129000.0 in 2021, then tumbled by 255.85% to 71629000.0 in 2022, then jumped by 63.76% to 25959000.0 in 2023, then plunged by 41.37% to 36698000.0 in 2024, then soared by 75.06% to 9151000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 9151000.0 (Q2 2025), 13240000.0 (Q1 2025), and 36698000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn | -9.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -9.15 Mn |
| Mar 31, 2025 | -13.24 Mn |
| Dec 31, 2024 | -36.70 Mn |
| Sep 30, 2024 | -12.65 Mn |
| Jun 30, 2024 | -16.55 Mn |
| Mar 31, 2024 | -9.65 Mn |
| Dec 31, 2023 | -25.96 Mn |
| Sep 30, 2023 | -8.66 Mn |
| Jun 30, 2023 | -28.34 Mn |
| Mar 31, 2023 | -4.87 Mn |
| Dec 31, 2022 | -71.63 Mn |
| Sep 30, 2022 | -15.69 Mn |
| Jun 30, 2022 | -7.05 Mn |
| Mar 31, 2022 | -11.63 Mn |
| Dec 31, 2021 | -20.13 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.03 Mn |